Angiodynamics (ANGO) Change in Inventory (2010 - 2026)

Angiodynamics (ANGO) has reported Change in Inventory for 17 consecutive years, with -$6.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Inventory fell 463.96% year-over-year to -$6.5 million; the trailing twelve-month figure through May 2026 stood at -$10.0 million (down 845.88% YoY), and the FY2026 full-year result was -$10.0 million, down 845.88% from the prior year.
• Change in Inventory improved to -$6.5 million in Q2 2026 per ANGO's latest filing, from -$7.1 million in the prior quarter.
• Across five years, Change in Inventory topped out at $6.2 million in Q3 2022 and bottomed at -$7.1 million in Q1 2026.
• Historically, Change in Inventory has averaged $676777.8 across 5 years, with a median of $836500.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Change in Inventory surged 905.71% in 2022, then plunged 577.3% in 2024.
• Over 5 years, Change in Inventory stood at $5.6 million in 2022, then slipped by 23.65% to $4.3 million in 2023, then tumbled by 70.73% to $1.2 million in 2024, then soared by 162.48% to $3.3 million in 2025, then slumped by 296.98% to -$6.5 million in 2026.
• According to Business Quant data, Change in Inventory over the past three periods registered -$6.5 million, -$7.1 million, and $3.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.